tirzepatide pricing
40% of Patients Overspend on Prescription Weight Loss
40% of patients overspend on prescription weight-loss drugs, paying more than they can afford for the medication. The surge in GLP-1 therapies like semaglutide and tirzepatide has expanded access, but costs have outpaced many insurance plans, leaving a large share of users with hefty out-of-pocket bills. Medical Disclaimer: This article